A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Active, not recruiting

Plain-English translation of NCT06257264 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(24 sites)

United States

Hoag Memorial Presbyterian, Newport Beach, California

Florida Cancer Specialists and Research Institute, Lake Mary, Florida

Washington University School of Medicine, St Louis, Missouri

Titan Health Partners Llc Dba Astera Cancer Care, East Brunswick, New Jersey

Avera Cancer Institute, Sioux Falls, South Dakota